BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4598115)

  • 1. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor.
    Vandenberg G; DeVane G; Yen SS
    J Clin Invest; 1974 Jun; 53(6):1750-4. PubMed ID: 4598115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.
    Wang CF; Yen SS
    J Clin Invest; 1975 Jan; 55(1):201-4. PubMed ID: 1088908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis.
    Yen SS; Rebar R; Vandenberg G; Ehara Y; Siler T
    J Reprod Fertil Suppl; 1973 Dec; 20(0):137-61. PubMed ID: 4599401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Interaction between gonadal steroids and LH-releasing hormone to control gonadotropin secretion at the pituitary level.
    Negro-Vilar A
    Acta Physiol Lat Am; 1973; 23(6):494-6. PubMed ID: 4604956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects.
    Wentz AC; Jones GS; Rocco L
    Obstet Gynecol; 1975 Mar; 45(3):239-46. PubMed ID: 1089927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
    Yagi S; Nakano R
    Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral contraceptives on the gonadotropin response to LHRH.
    Rubinstein L; Moguilevsky J; Leiderman S
    Obstet Gynecol; 1978 Nov; 52(5):571-4. PubMed ID: 364356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gonadal steroids on the pituitary gonadotrophin response to luteinizing hormone releasing factor (LRF) in the rat.
    Nakano R; Kayashima F; Kotsuji F; Tojo S
    Endokrinologie; 1974 Mar; 63(1):147-54. PubMed ID: 4611760
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
    Lachelin GC; Yen SS
    J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructure of rat pituitary gonadotrophs after injection of synthetic luteinizing hormone releasing factor (LRF).
    Nakano R; Lee W; Hayashi K; Tojo S
    Endokrinologie; 1975 Feb; 65(1):60-5. PubMed ID: 1100366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of pituitary responsiveness to LRF by estrogen.
    Yen SS; Vandenberg G; Siler TM
    J Clin Endocrinol Metab; 1974 Jul; 39(1):170-7. PubMed ID: 4600507
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
    Schally AV; Parlow AF; Carter WH; Saito M; Bowers CY; Arimura A
    Endocrinology; 1970 Mar; 86(3):530-41. PubMed ID: 4188612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of synthetic sex steroids on the pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) (author's transl)].
    Higashiyama S; Iwasaki T; Kizu S; Okada H
    Nihon Naibunpi Gakkai Zasshi; 1976 Jan; 52(1):72-82. PubMed ID: 767171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.